Location History:
- Tallahassee, FL (US) (2017 - 2018)
- Silver Spring, MD (US) (2020)
- Washington, DC (US) (2024)
Company Filing History:
Years Active: 2017-2024
Title: Innovations by Matthieu F Dumont
Introduction
Matthieu F Dumont is an accomplished inventor based in Tallahassee, Florida. He has made significant contributions to the field of medical technology, particularly in the development of innovative treatments and devices. With a total of four patents to his name, Dumont's work focuses on enhancing patient care through advanced materials and methods.
Latest Patents
Dumont's latest patents include groundbreaking inventions such as functionalized Prussian blue nanoparticles. These nanoparticles are designed for use in combination therapies, specifically targeting cancer treatment through innovative nano-immunotherapy approaches. His work on stable, functionalized Prussian blue nanoparticles emphasizes their enhanced stability under alkaline conditions, which is crucial for effective cancer, neoplasm, and tumor treatments. Another notable invention is the dissolvable on-command implant, which serves as a pressure equalizer tube in the eardrum. This unique implant can be dissolved using a specially formulated drop solution, allowing for effective drainage of middle ear fluid and ventilation of the middle ear space.
Career Highlights
Dumont is currently affiliated with the Children's National Medical Center, where he continues to push the boundaries of medical innovation. His work is characterized by a commitment to improving patient outcomes through the application of advanced technologies.
Collaborations
Dumont collaborates with talented individuals such as Rohan Fernandes and Raymond W Sze, contributing to a dynamic environment of innovation and research.
Conclusion
Matthieu F Dumont exemplifies the spirit of innovation in the medical field through his patents and collaborative efforts. His contributions are paving the way for new treatments and technologies that enhance patient care and improve health outcomes.